大葉大學圖書館 |

Pharmacological treatment of chronic stable angina pectoris[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	616.122061
書名/作者:	Pharmacological treatment of chronic stable angina pectoris/ edited by Pablo Avanzas, Juan Carlos Kaski.
其他作者:	Avanzas, Pablo.
出版者:	Cham : : Springer International Publishing :, 2015.
面頁冊數:	xi, 278 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Angina pectoris - Chemotherapy.
標題:	Medicine & Public Health.
標題:	Cardiology.
ISBN:	9783319173320 (electronic bk.)
ISBN:	9783319173313 (paper)
內容註:	Mechanisms of angina -- An overview of treatment and guidelines - ESC /ACC-AHA/ NICE -- Beta-blockers -- Calcium channel blockers -- Nitrates -- Nicorandil -- Ivabradine. Trimetazidine -- Ranolazine -- New antianginal drugs still not available for clinical use -- Medical therapy versus revascularization in the management of stable angina pectoris.
摘要、提要註:	This book describes the clinical challenge currently posed by stable angina pectoris and provides guidance for those making clinical decisions regarding its pharmacological treatment. The importance of providing effective treatment is beyond dispute and this book deals with the most relevant aspects related to its pharmacological treatment. The pathogenesis of myocardial ischemia as the basis for rational treatment of angina is discussed thoroughly together with all major management goals including optimal symptom control and the secondary prevention of serious cardiovascular events. Pharmacological Treatment of Chronic Stable Angina Pectoris provides a clear description of the mechanisms of action and clinical indications of available anti-angina drugs and strategies for the use of novel pharmacological agents. It also includes a critical appraisal of the major management guidelines, which will assist the reader to interpret current evidence and provide the most appropriate forms of treatment. The ongoing controversy regarding medical therapy versus myocardial revascularization for the management of stable angina pectoris is also addressed. This eminently practical book will help guiding the reader through the complexities of the field and will be highly appreciated by clinicians, clinical cardiologists and cardiology trainees alike.
電子資源:	http://dx.doi.org/10.1007/978-3-319-17332-0

Pharmacological treatment of chronic stable angina pectoris[electronic resource] /
Pharmacological treatment of chronic stable angina pectoris[electronic resource] /edited by Pablo Avanzas, Juan Carlos Kaski. - Cham :Springer International Publishing :2015. - xi, 278 p. :ill., digital ;24 cm. - Current cardiovascular therapy. - Current cardiovascular therapy..

Mechanisms of angina -- An overview of treatment and guidelines - ESC /ACC-AHA/ NICE -- Beta-blockers -- Calcium channel blockers -- Nitrates -- Nicorandil -- Ivabradine. Trimetazidine -- Ranolazine -- New antianginal drugs still not available for clinical use -- Medical therapy versus revascularization in the management of stable angina pectoris.

This book describes the clinical challenge currently posed by stable angina pectoris and provides guidance for those making clinical decisions regarding its pharmacological treatment. The importance of providing effective treatment is beyond dispute and this book deals with the most relevant aspects related to its pharmacological treatment. The pathogenesis of myocardial ischemia as the basis for rational treatment of angina is discussed thoroughly together with all major management goals including optimal symptom control and the secondary prevention of serious cardiovascular events. Pharmacological Treatment of Chronic Stable Angina Pectoris provides a clear description of the mechanisms of action and clinical indications of available anti-angina drugs and strategies for the use of novel pharmacological agents. It also includes a critical appraisal of the major management guidelines, which will assist the reader to interpret current evidence and provide the most appropriate forms of treatment. The ongoing controversy regarding medical therapy versus myocardial revascularization for the management of stable angina pectoris is also addressed. This eminently practical book will help guiding the reader through the complexities of the field and will be highly appreciated by clinicians, clinical cardiologists and cardiology trainees alike.

ISBN: 9783319173320 (electronic bk.)

Standard No.: 10.1007/978-3-319-17332-0doiSubjects--Topical Terms:

627703
Angina pectoris
--Chemotherapy.

LC Class. No.: RC684.C48

Dewey Class. No.: 616.122061

Pharmacological treatment of chronic stable angina pectoris[electronic resource] /
LDR:02703nam a2200325 a 4500 001 439592
003 DE-He213
005 20160125134550.0
006 m d
007 cr nn 008maaau
008 160322s2015 gw s 0 eng d
020 $a 9783319173320 (electronic bk.)
020 $a 9783319173313 (paper)
024 7 $a 10.1007/978-3-319-17332-0 $2 doi
035 $a 978-3-319-17332-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RC684.C48
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
082 0 4 $a 616.122061 $2 23
090 $a RC684.C48 $b P536 2015
245 0 0 $a Pharmacological treatment of chronic stable angina pectoris $h [electronic resource] / $c edited by Pablo Avanzas, Juan Carlos Kaski.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a xi, 278 p. : $b ill., digital ; $c 24 cm.
490 1 $a Current cardiovascular therapy
505 0 $a Mechanisms of angina -- An overview of treatment and guidelines - ESC /ACC-AHA/ NICE -- Beta-blockers -- Calcium channel blockers -- Nitrates -- Nicorandil -- Ivabradine. Trimetazidine -- Ranolazine -- New antianginal drugs still not available for clinical use -- Medical therapy versus revascularization in the management of stable angina pectoris.
520 $a This book describes the clinical challenge currently posed by stable angina pectoris and provides guidance for those making clinical decisions regarding its pharmacological treatment. The importance of providing effective treatment is beyond dispute and this book deals with the most relevant aspects related to its pharmacological treatment. The pathogenesis of myocardial ischemia as the basis for rational treatment of angina is discussed thoroughly together with all major management goals including optimal symptom control and the secondary prevention of serious cardiovascular events. Pharmacological Treatment of Chronic Stable Angina Pectoris provides a clear description of the mechanisms of action and clinical indications of available anti-angina drugs and strategies for the use of novel pharmacological agents. It also includes a critical appraisal of the major management guidelines, which will assist the reader to interpret current evidence and provide the most appropriate forms of treatment. The ongoing controversy regarding medical therapy versus myocardial revascularization for the management of stable angina pectoris is also addressed. This eminently practical book will help guiding the reader through the complexities of the field and will be highly appreciated by clinicians, clinical cardiologists and cardiology trainees alike.
650 0 $a Angina pectoris $x Chemotherapy. $3 627703
650 1 4 $a Medicine & Public Health. $3 463493
650 2 4 $a Cardiology. $3 189244
700 1 $a Avanzas, Pablo. $3 612347
700 1 $a Kaski, Juan Carlos. $3 627702
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a Current cardiovascular therapy. $3 613555
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-17332-0
950 $a Medicine (Springer-11650)